In addition, another novel SLC7A11 inhibitor, HG106, exhibited specific cytotoxicity against KRAS-mutant lung adenocarcinoma cells by inducing cell apoptosis through enhanced oxidative stress and ER stress pathways.100. The gene discussed is KRAS; the disease is lung adenocarcinoma.